Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Peters, Slotkin, Walberg, and Huizenga Call on Small Business Administration to Approve Disaster Declaration to Assist Communities Impacted by Southwest Michigan Tornadoes